{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:12Z","timestamp":1753891092370,"version":"3.41.2"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid tissues (TLTs) are ectopic lymphoid tissues that form <jats:italic>de novo<\/jats:italic> in nonlymphoid organs. In this study, we demonstrate that the kidneys of aged mice with a renal tubule-specific knockout of autophagy-related 7 (Atg7) contain numerous and large TLTs. p-S6 protein, a marker of mTORC1, was elevated in the tubules adjacent to the TLTs as well as within the TLTs themselves. In Atg7<jats:sup>\u2212\/\u2212<\/jats:sup> kidneys, tubular injury and increased proinflammatory cytokines were observed, both of which are known to promote TLT formation and growth. In mice with either polycystic kidney disease (Pkd1<jats:sup>RC\/RC<\/jats:sup>) or kidney ischemia, increased p-S6 was observed in tubules near TLTs and within the TLTs. Treatment with Torin2, an mTOR inhibitor, led to the virtual disappearance of TLTs in Pkd1<jats:sup>RC\/RC<\/jats:sup> kidneys and a significant reduction in TLTs in ischemic kidneys. To assess whether p-S6 in the tubules was driving TLT formation, ischemia was induced in tubule-specific Atg7<jats:sup>\u2212\/\u2212<\/jats:sup> Raptor (mTORC1)<jats:sup>\u2212\/\u2212<\/jats:sup> mice. The tubule-specific Raptor knockout had little effect on the TLTs. In summary, Torin2, which inhibited p-S6 in both tubules and TLTs, resulted in a large decrease in TLTs in ischemic and Pkd1<jats:sup>RC\/RC<\/jats:sup> kidneys. Tubule-specific knockout of mTORC1 (Raptor) had no effect on TLTs. In conclusion, p-S6 activity within the TLTs, rather than in the tubules, drives the proliferation of immune cells and the formation and growth of TLTs. These findings provide new insights into the role of mTOR in TLT development. The study has important therapeutic implications, as TLTs are involved in numerous disease processes and mTOR inhibitors are widely used in clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1527817","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:11:24Z","timestamp":1748319084000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney"],"prefix":"10.3389","volume":"16","author":[{"given":"Daniel J.","family":"Atwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkesh","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth B.","family":"Furgeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Faubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab212","article-title":"Tertiary lymphoid tissues: a regional hub for kidney inflammation","author":"Sato","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.02.023","article-title":"Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys","volume":"98","author":"Sato","year":"2020","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01150113","article-title":"Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy","volume":"9","author":"Pei","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001983","article-title":"In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis","volume":"186","author":"Chang","year":"2011","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.191","article-title":"Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis","volume":"74","author":"Steinmetz","year":"2008","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/ASN.2021050715","article-title":"Advanced tertiary lymphoid tissues in protocol biopsies are associated with progressive graft dysfunction in kidney transplant recipients","volume":"33","author":"Lee","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.11.010","article-title":"Inhaled fine particles induce alveolar macrophage death and interleukin-1alpha release to promote inducible bronchus-associated lymphoid tissue formation","volume":"45","author":"Kuroda","year":"2016","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B11","article-title":"Polycystic kidney disease","volume-title":"Diseases of the Kidney and Urinary Tract. 2","author":"Schrier","year":"2007"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semnephrol.2013.11.005","article-title":"Polycystic kidney disease: a case of suppressed autophagy","volume":"34","author":"Ravichandran","year":"2014","journal-title":"Semin Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655731","article-title":"The mTOR-autophagy axis and the control of metabolism","volume":"9","author":"Deleyto-Seldas","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.3390\/ijms21218045","article-title":"B cell activating factor (BAFF) is required for the development of intra-renal tertiary lymphoid organs in experimental kidney transplantation in rats","volume":"21","author":"Steines","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146071","article-title":"CD153\/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury","volume":"132","author":"Sato","year":"2022","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000202","article-title":"Tertiary lymphoid tissues are microenvironments with intensive interactions between immune cells and proinflammatory parenchymal cells in aged kidneys","volume":"34","author":"Yoshikawa","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000873","article-title":"Tertiary lymphoid structures: diversity in their development, composition, and role","volume":"206","author":"Gago da Graca","year":"2021","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cytogfr.2017.04.005","article-title":"Control of B lymphocyte development and functions by the mTOR signaling pathways","volume":"35","author":"Iwata","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.05.002","article-title":"mTOR and lymphocyte metabolism","volume":"25","author":"Zeng","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016444.90348.50","article-title":"Epithelial-specific Cre\/lox recombination in the developing kidney and genitourinary tract","volume":"13","author":"Shao","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016443.50138.CD","article-title":"A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract","volume":"13","author":"Shao","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.06.025","article-title":"CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression","volume":"94","author":"Kleczko","year":"2018","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00051.2019","article-title":"A study of sirolimus and an mTOR kinase inhibitor (TORKi) in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (ADPKD)","volume":"317","author":"Holditch","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1702","article-title":"Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR","volume":"73","author":"Liu","year":"2013","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz244","article-title":"The consequences of increased 4E-BP1 in polycystic kidney disease","volume":"28","author":"Holditch SJ","year":"2019","journal-title":"Hum Molec Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.205732","article-title":"NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury","volume":"346","author":"Kim","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87680","article-title":"Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney","volume":"1","author":"Sato","year":"2016","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88646","article-title":"Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells","volume":"1","author":"Masuda","year":"2016","journal-title":"JCI Insight"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.11.013","article-title":"IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injury","volume":"97","author":"Skrypnyk","year":"2020","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"23","author":"Ravichandran","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/ndt\/gfu296","article-title":"An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease (PKD)","volume":"30","author":"Ravichandran","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00129.2010","article-title":"mTORC1\/2 and rapamycin in female Han: SPRD rats with polycystic kidney disease","volume":"300","author":"Belibi","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.135103","article-title":"New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress","volume":"285","author":"Ayuso","year":"2010","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"109518","DOI":"10.1016\/j.cellsig.2019.109518","article-title":"Apoptosis and autophagy in polycystic kidney disease (PKD)","volume":"68","author":"Nowak","year":"2020","journal-title":"Cell Signal"},{"key":"B41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114824","article-title":"Emerging roles of ATG7 in human health and disease","volume":"13","author":"Collier","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/biomedicines9070707","article-title":"The pathways underlying the multiple roles of p62 in inflammation and cancer","volume":"9","author":"Hennig","year":"2021","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","article-title":"p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation","volume":"21","author":"Liu","year":"2016","journal-title":"Cell Mol Biol Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000079785.13922.F6","article-title":"Recent advances in the pathophysiology of ischemic acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.13.6067-6075.2004","article-title":"Immune functions in mice lacking Clnk, an SLP-76-related adaptor expressed in a subset of immune cells","volume":"24","author":"Utting","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040374","article-title":"New autophagy reporter mice reveal dynamics of proximal tubular autophagy","volume":"25","author":"Li","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13431","article-title":"mTORC2: The other mTOR in autophagy regulation","volume":"20","author":"Ballesteros-Alvarez","year":"2021","journal-title":"Aging Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"109605","DOI":"10.1016\/j.cellsig.2020.109605","article-title":"The effect of MEK1\/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice","volume":"71","author":"Brown","year":"2020","journal-title":"Cell Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"216293","DOI":"10.1016\/j.canlet.2023.216293","article-title":"Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy","volume":"568","author":"Li","year":"2023","journal-title":"Cancer Lett"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215623","article-title":"Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice","volume":"110","author":"Melnikov","year":"2002","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00352.2012","article-title":"Mouse model of ischemic acute kidney injury: technical notes and tricks","volume":"303","author":"Wei","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.20","article-title":"Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis","volume":"82","author":"Grgic","year":"2012","journal-title":"Kidney Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.12.015","article-title":"SQSTM1\/p62 regulates the production of IL-8 and MCP-1 in IL-1beta-stimulated human retinal pigment epithelial cells","volume":"116","author":"Korhonen","year":"2019","journal-title":"Cytokine"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.285","article-title":"TNF receptors: signaling pathways and contribution to renal dysfunction","volume":"87","author":"Al-Lamki","year":"2015","journal-title":"Kidney Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/nep.2013.18.issue-5","article-title":"Role of interstitial inflammation in the pathogenesis of polycystic kidney disease","volume":"18","author":"Ta","year":"2013","journal-title":"Nephrol (Carlton)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402352111","article-title":"mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress","volume":"111","author":"Grahammer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.281.4.F693","article-title":"Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells","volume":"281","author":"Lieberthal","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the mTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-mediated regulation of dendritic cell differentiation and function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.01.009","article-title":"Autophagy in cellular growth control","volume":"584","author":"Wang","year":"2010","journal-title":"FEBS Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fonc.2020.01037","article-title":"Interplay between autophagy and wnt\/beta-catenin signaling in cancer: therapeutic potential through drug repositioning","volume":"10","author":"Perez-Plasencia","year":"2020","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091850","article-title":"Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice","volume":"9","author":"Huang","year":"2014","journal-title":"PloS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/genes8030088","article-title":"MYC in regulating immunity: metabolism and beyond","volume":"8","author":"Gnanaprakasam","year":"2017","journal-title":"Genes (Basel)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.02.1435","article-title":"Narrative review of immunomodulatory and anti-inflammatory effects of sodium-glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers","volume":"9","author":"Lee","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v198.4","article-title":"Empagliflozin modulates CD4(+) T-cell differentiation via metabolic reprogramming in immune thrombocytopenia","volume":"198","author":"Qin","year":"2022","journal-title":"Br J Haematol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1177221","article-title":"Ribosomal protein S6 kinase 1 signaling regulates mammalian life span","volume":"326","author":"Selman","year":"2009","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1527817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:11:25Z","timestamp":1748319085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1527817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2025.1527817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1527817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"article-number":"1527817"}}